Companies Contain Fallout

J&J and Profectus may successfully argue that the primate aerosol challenge findings did not translate into human clinical risk. If independent experts or regulators accept that framing, the event remains a reputational issue rather than a commercial one.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.